These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 22001526

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Analysis of plasmin generation and clot lysis of plasma fibrinogen purified from a heterozygous dysfibrinogenemia, BbetaGly15Cys (Hamamatsu II).
    Kamijyo Y, Hirota-Kawadobora M, Yamauchi K, Terasawa F, Honda T, Ikeya M, Okumura N.
    Blood Coagul Fibrinolysis; 2009 Dec; 20(8):726-32. PubMed ID: 19809304
    [Abstract] [Full Text] [Related]

  • 3. Comparison of molecular structure and fibrin polymerization between two Bβ-chain N-terminal region fibrinogen variants, Bβp.G45C and Bβp.R74C.
    Kaido T, Yoda M, Kamijo T, Taira C, Higuchi Y, Okumura N.
    Int J Hematol; 2020 Sep; 112(3):331-340. PubMed ID: 32562089
    [Abstract] [Full Text] [Related]

  • 4. A novel mutation in the FGB: c.1105C>T turns the codon for amino acid Bβ Q339 into a stop codon causing hypofibrinogenemia.
    Marchi R, Brennan S, Meyer M, Rojas H, Kanzler D, De Agrela M, Ruiz-Saez A.
    Blood Cells Mol Dis; 2013 Mar; 50(3):177-81. PubMed ID: 23266225
    [Abstract] [Full Text] [Related]

  • 5. A C-terminal amino acid substitution in the gamma-chain caused by a novel heterozygous frameshift mutation (Fibrinogen Matsumoto VII) results in hypofibrinogenaemia.
    Fujihara N, Haneishi A, Yamauchi K, Terasawa F, Ito T, Ishida F, Okumura N.
    Thromb Haemost; 2010 Aug; 104(2):213-23. PubMed ID: 20589319
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Differences in the function and secretion of congenital aberrant fibrinogenemia between heterozygous γD320G (Okayama II) and γΔN319-ΔD320 (Otsu I).
    Mukai S, Ikeda M, Takezawa Y, Sugano M, Honda T, Okumura N.
    Thromb Res; 2015 Dec; 136(6):1318-24. PubMed ID: 26573395
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Fibrinogen St. Gallen I (gamma 292 Gly--> Val): evidence for structural alterations causing defective polymerization and fibrinogenolysis.
    Stucki B, Schmutz P, Schmid L, Haeberli A, Lämmle B, Furlan M.
    Thromb Haemost; 1999 Feb; 81(2):268-74. PubMed ID: 10064005
    [Abstract] [Full Text] [Related]

  • 12. [Comparison of fibrinogen synthesis and secretion between novel variant fibrinogen, nagakute (gamma305Thr --> Ala), and other variants located in gamma305-308 residues].
    Kobayashi T, Takezawa Y, Terasawa F, Okumura N.
    Rinsho Byori; 2012 Sep; 60(9):831-8. PubMed ID: 23157111
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [A case of dysfibrinogenemia without hemorrhagic diathesis or thromboembolism linked to a new mutation p.H103N in fibrinogen γ chain].
    Devignes J, Hanss M, Chabaud A, Toussaint-Hacquard M, Mansuy L, De Mazancourt P, Lecompte T.
    Ann Biol Clin (Paris); 2013 Sep; 71(4):489-95. PubMed ID: 23906582
    [Abstract] [Full Text] [Related]

  • 15. A novel variant fibrinogen, deletion of Bbeta111Ser in coiled-coil region, affecting fibrin lateral aggregation.
    Okumura N, Terasawa F, Hirota-Kawadobora M, Yamauchi K, Nakanishi K, Shiga S, Ichiyama S, Saito M, Kawai M, Nakahata T.
    Clin Chim Acta; 2006 Mar; 365(1-2):160-7. PubMed ID: 16229829
    [Abstract] [Full Text] [Related]

  • 16. Fibrinogen Šumperk II: dysfibrinogenemia in an individual with two coding mutations.
    Kotlín R, Suttnar J, Cápová I, Hrachovinová I, Urbánková M, Dyr JE.
    Am J Hematol; 2012 May; 87(5):555-7. PubMed ID: 22407772
    [Abstract] [Full Text] [Related]

  • 17. In vitro fibrin clot formation and fibrinolysis using heterozygous plasma fibrinogen from gammaAsn319, Asp320 deletion dysfibrinogen, Otsu I.
    Terasawa F, Kani S, Hongo M, Okumura N.
    Thromb Res; 2006 May; 118(5):651-61. PubMed ID: 16412498
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.